Skip to main content

and
  1. No Access

    Article

    Challenges and opportunities for biomarker discovery to predict imminent myocardial infarction

    In coronary artery disease, the transition from an apparently stable state to a life-threatening acute cardiac event is difficult to predict. As such, a recent study applied proteomic and metabolomic approache...

    Marie de Bakker, Dorien M. Kimenai, Nicholas L. Mills in Nature Cardiovascular Research (2024)

  2. Article

    Open Access

    Trajectories of cardiac troponin in the decades before cardiovascular death: a longitudinal cohort study

    High-sensitivity cardiac troponin testing is a promising tool for cardiovascular risk prediction, but whether serial testing can dynamically predict risk is uncertain. We evaluated the trajectory of cardiac tr...

    Dorien M. Kimenai, Atul Anand, Marie de Bakker, Martin Shipley in BMC Medicine (2023)

  3. Article

    Open Access

    Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial

    Metformin has favorable effects on cardiovascular outcomes in both newly onset and advanced type 2 diabetes, as previously reported findings from the UK Prospective Diabetes Study and the HOME trial have demon...

    Johanna M. G. Stultiens, Wiebe M. C. Top, Dorien M. Kimenai in Cardiovascular Diabetology (2022)

  4. Article

    Open Access

    The “hype” of hydrops in classifying vestibular disorders: a narrative review

    Classifying and diagnosing peripheral vestibular disorders based on their symptoms is challenging due to possible symptom overlap or atypical clinical presentation. To improve the diagnostic trajectory, gadoli...

    Marly F. J. A. van der Lubbe, Akshayaa Vaidyanathan in Journal of Neurology (2020)

  5. Article

    Open Access

    Sex-specific effects of implementing a high-sensitivity troponin I assay in patients with suspected acute coronary syndrome: results from SWEDEHEART registry

    Using high-sensitivity cardiac troponin (hs-cTn) assays with sex-specific 99th percentiles may improve management of patients with suspected acute myocardial infarction (AMI). We investigated the impact of tra...

    Dorien M. Kimenai, Bertil Lindahl, Tomas Jernberg, Otto Bekers in Scientific Reports (2020)

  6. No Access

    Chapter

    Sex-Related Aspects of Biomarkers in Cardiac Disease

    Biomarkers play an important role in the clinical management of cardiac care. In particular, cardiac troponins (cTn) and natriuretic peptides are the cornerstones for the diagnosis of acute myocardial infarcti...

    Alma M. A. Mingels, Dorien M. Kimenai in Sex-Specific Analysis of Cardiovascular Function (2018)

  7. Article

    Open Access

    Troponin I and T in relation to cardiac injury detected with electrocardiography in a population-based cohort - The Maastricht Study

    Interest in high-sensitivity cardiac troponin I(hs-cTnI) and T(hs-cTnT) has expanded from acute cardiac care to cardiovascular disease(CVD) risk stratification. Whether hs-cTnI and hs-cTnT are interchangeable ...

    Dorien M. Kimenai, Remy J. H. Martens, Jeroen P. Kooman in Scientific Reports (2017)